rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
1997-7-31
|
pubmed:abstractText |
S100 proteins are low-molecular-weight calcium-binding proteins and appear to play an important role in various cellular processes such as cell division and differentiation. In histopathology, S100 is widely accepted as the marker of choice for immunohistochemical identification of malignant melanoma. When S100 was detected in the serum of patients with malignant melanoma, it was suggested that serum S100 may be a useful marker for the stage of disease.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1018-8665
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
194
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
208-12
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9187834-Adult,
pubmed-meshheading:9187834-Cell Differentiation,
pubmed-meshheading:9187834-Cell Division,
pubmed-meshheading:9187834-Disease Progression,
pubmed-meshheading:9187834-Female,
pubmed-meshheading:9187834-Follow-Up Studies,
pubmed-meshheading:9187834-Humans,
pubmed-meshheading:9187834-Hutchinson's Melanotic Freckle,
pubmed-meshheading:9187834-Immunohistochemistry,
pubmed-meshheading:9187834-Liver Neoplasms,
pubmed-meshheading:9187834-Lymphatic Metastasis,
pubmed-meshheading:9187834-Male,
pubmed-meshheading:9187834-Melanoma,
pubmed-meshheading:9187834-Middle Aged,
pubmed-meshheading:9187834-Neoplasm Staging,
pubmed-meshheading:9187834-Remission Induction,
pubmed-meshheading:9187834-S100 Proteins,
pubmed-meshheading:9187834-Skin Neoplasms,
pubmed-meshheading:9187834-Tumor Markers, Biological
|
pubmed:year |
1997
|
pubmed:articleTitle |
Serum S100--a marker for disease monitoring in metastatic melanoma.
|
pubmed:affiliation |
Department of Dermatology, University Hospital of Zurich, Switzerland.
|
pubmed:publicationType |
Journal Article,
Case Reports
|